Functional complementation of the envelope hypervariable V3 loop of human immunodeficiency virus type 1 subtype B by the subtype E V3 loop

Virology

Volumn 257, Issue 2, 1999, Pages 491-501

  Sato, Hironori ^a   Kato, Kayoko ^a   Takebe, Yutaka ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; GLYCOPROTEIN GP 120;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; GENETIC COMPLEMENTATION; HELPER CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DOMAIN; STRUCTURE ACTIVITY RELATION; VIRUS ENVELOPE; VIRUS RECOMBINANT;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0033541972     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1999.9670     Document Type: Article

References (64)

1. Alkhatib G., Combadiere C., Broder C. C., Feng Y., Kennedy P. E., Murphy P. M., Berger E. A. CC CKR5: A RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science. 272:1996;1955-1958.
2. Batinic D., Robey F. A. The V3 region of the envelope glycoprotein of human immunodeficiency virus type 1 binds sulfated polysaccharides and CD4-derived synthetic peptides. J. Biol. Chem. 267:1992;6664-6671.
3. Bhattacharyya D., Brooks B. R., Callahan L. Positioning of positively charged residues in the V3 loop correlates with HIV type 1 syncytium-inducing phenotype. AIDS Res. Hum. Retroviruses. 12:1996;83-90.
4. Bjorndal A., Deng H., Jansson M., Fiore J., Colognesi C., Karlsson A., Albert J., Scarlatti G., Littman D., Fenyo E. Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype. J. Virol. 71:1997;7478-7487.
5. Bonhoeffer S., Holmes S. E., Nowak M. Causes of HIV diversity. Nature. 376:1995;125.
6. Callahan L. N., Phelan M., Mallinson M., Norcross M. A. Dextran sulfate blocks antibody binding to the principal neutralizing domain of human immunodeficiency virus type 1 without interfering with gp120-CD4 interactions. J. Virol. 65:1991;1543-1550.
7. Cassol S., Weniger B. G., Babu P. G., Salminen M. O., Zheng X., Htoon M. T., Delaney A., O'Shaughnessy M., Ou C. Y. Detection of HIV type 1 env subtypes A, B, C, and E in Asia using dried blood spots: A new surveillance tool for molecular epidemiology. AIDS Res. Hum. Retroviruses. 12:1996;1435-1441.
8. Chesebro B., Wehrly K., Nishio J., Perryman S. Macrophage-tropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-cell-tropic isolates: Definition of critical amino acids involved in cell tropism. J. Virol. 66:1992;6547-6554.
9. Cho M., Lee M., Carney M., Berson J., Doms R., Martin M. Identification of determinants on a dualtropic human immunodeficiency virus type 1 envelope glycoprotein that confer usage of CXCR4. J. Virol. 72:1998;2509-2515.
10. Choe H., Farzan M., Sun Y., Sullivan N., Rollins B., Ponath P. D., Wu L., Mackay C. R., LaRosa G., Newman W., Gerard N., Gerard C., Sodroski J. The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell. 85:1996;1135-1148.
11. +. Science. 270:1995;1811-1815.
12. Cocchi F., DeVico A., Garzino-Demo A., Cara A., Gallo R., Lusso P. The V3 domain of the HIV-1 gp120 envelope glycoprotein is critical for chemokine-mediated blockade of infection. Nat. Med. 2:1996;1244-1247.
13. Connor R., Sheridan K., Ceradini D., Choe S., Landau N. Change in coreceptor use correlates with disease progression in HIV-1-infected individuals. J. Exp. Med. 185:1997;621-628.
14. de Jong J.-J., de Ronde A., Keulen W., Tersmette M., Goudsmit J. Minimal requirements for the human immunodeficiency virus type 1 V3 domain to support the syncytium-inducing phenotype: Analysis by single amino acid substitution. J. Virol. 66:1992a;6777-6780.
15. de Jong J.-J., Goudsmit J., Keulen W., Klaver B., Krone W., Tersmette M., de Ronde A. Human immunodeficiency virus type 1 clones chimeric for the envelope V3 domain differ in syncytium formation and replication capacity. J. Virol. 66:1992b;757-765.
16. De Wolf F., Hogervorst E., Goudsmit J., Fenyo E. M., Rubsamen-Waigmann H., Holmes H., Galvao-Castro B., Karita E., Wasi C., Sempala S. D., Baan E., Zorgdrager F., Lukashov V., Osmanov S., Kuiken C., Cornelissen M., CHARACTERIZATION W. N. F. I. A. Syncytium-inducing and non-syncytium-inducing capacity of human immunodeficiency virus type 1 subtypes other than B: Phenotypic and genotypic characteristics. WHO Network for HIV Isolation and Characterization. AIDS Res. Hum. Retroviruses. 10:1994;1387-1400.
17. Deng H., Liu R., Wilfried E., Choe S., Unutmaz D., Burkhart M., Di Marzio P., Marmon S., Sutton R., Hill M., Davis C., Peiper S., Schall T., Littman D., Landau N. Identification of a major co-receptor for primary isolates of HIV-1. Nature. 381:1996;661-666.
18. Dittmar M. T., Simmons G., Hibbitts S., O'Hare M., Louisirirotchanakul S., Beddows S., Weber J., Clapham P. R., Weiss R. A. Langerhans cell tropism of human immunodeficiency virus type 1 subtype A through F isolates derived from different transmission groups. J. Virol. 71:1997;8008-8013.
19. +. Nature. 381:1996;667-673.
20. Dragic T., Trkola A., Lin S., Nagashima K., Kajumo F., Zhao L., Olson W., Wu L., Mackay C., Allaway G., Sakmar T., Moore J., Maddon P. Amino-terminal substitutions in the CCR5 coreceptor impair gp120 binding and human immunodeficiency virus type 1 entry. J. Virol. 72:1998;279-285.
21. Fouchier R., Brouwer M., Broersen S., Schuitemaker H. Simple determination of human immunodeficiency virus type 1 syncytium-inducing V3 genotype by PCR. J. Clin. Microbiol. 33:1995;906-911.
22. Fouchier R. A. M., Groenink M., Kootstra N. A., Tersmette M., Huisman H. G., Miedema F., Schuitemaker H. Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule. J. Virol. 66:1992;3183-3187.
23. Ho S., Hunt H., Horton R., Pullen J., Pease L. Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene. 77:1989;51-59.
24. Ichimura H., Kliks S., Visrutaratna S., Ou C.-Y., Kalish M., Levy J. Biological, serological, and genetic characterization of HIV-1 subtype E isolates from northern Thailand. AIDS Res. Hum. Retroviruses. 10:1994;263-269.
25. Koot M., van't Wout A. B., Kootstra N. A., de Goede R. E., Tersmette M., Schuitemaker H. Relation between changes in cellular load, evolution of viral phenotype, and the clonal composition of virus populations in the course of human immunodeficiency virus type 1 infection. J. Infect. Dis. 173:1996;349-354.
26. Kuiken C. L., de Jong J.-J., Baan E., Keulen W., Tersmette M., Goudsmit J. Evolution of the V3 envelope domain in proviral sequences and isolates of human immunodeficiency virus type 1 during transition of the viral biological phenotype. J. Virol. 66:1992;4622-4627.
27. Kuipers M. E., Huisman J. G., Swart P. J., de Bethune M. P., Pauwels R., Schuitemaker H., De Clercq E., Meijer D. K. Mechanism of anti-HIV activity of negatively charged albumins: Biomolecular interaction with the HIV-1 envelope protein gp120. J. Acq. Immune Defic. Syndr. Hum. Retrovirol. 11:1996;419-429.
28. Kusagawa S., Sato H., Kato K., Nohtomi K., Shiino T., Samrith C., Leng H., Phalla T., Heng M., Takebe Y. HIV type 1env. AIDS Res. Hum. Retroviruses. 15:1999;91-94.
29. Kusagawa S., Sato H., Watanabe S., Nohtomi K., Kato K., Shiino T., Thwe M., Oo K., Lwin S., Mra R., Kywe B., Yamazaki S., Takebe Y. Genetic and serologic characterization of HIV type 1 prevailing in Myanmar (Burma). AIDS Res. Hum. Retroviruses. 14:1998;1379-1385.
30. Loue S., Bounlu K., Pholsena V., Mastro T. D. HIV seroprevalence and HIV-1 subtype E among pregnant women in Vientiane, Laos. AIDS. 12:1998;1403.
31. Lukashov V. V., Kuiken C. L., Goudsmit J. Intrahost human immunodeficiency virus type 1 evolution is related to length of the immunocompetent period. J. Virol. 69:1995;6911-6916.
32. McCutchan F. E., Hegerich P. A., Brennan T. P., Phanuphak P., Singharaj P., Jugsudee A., Berman P. W., Gray A. M., Fowler A. K., Burke D. S. Genetic variants of HIV-1 in Thailand. AIDS Res. Hum. Retroviruses. 8:1992;1887-1895.
33. Menu E., Truong T. X., Lafon M. E., Nguyen T. H., Muller-Trutwin M. C., Nguyen T. T., Deslandres A., Chaouat G., Duong Q. T., Ha B. K., Fleury H. J., Barre-Sinoussi F. HIV type 1 Thai subtype E is predominant in South Vietnam. AIDS Res. Hum. Retroviruses. 12:1996;629-633.
34. Milich L., Margolin B., Swanstrom R. V3 loop of the human immunodeficiency virus type 1 Env protein: Interpreting sequence variability. J. Virol. 67:1993;5623-5634.
35. Montano M. A., Nixon C. P., Essex M. Dysregulation through the NF-kappaB enhancer and TATA box of the human immunodeficiency virus type 1 subtype E promoter. J. Virol. 72:1998;8446-8452.
36. Montano M. A., Novitsky V. A., Blackard J. T., Cho N. L., Katzenstein D. A., Essex M. Divergent transcriptional regulation among expanding human immunodeficiency virus type 1 subtypes. J. Virol. 71:1997;8657-8665.
37. Myers, G. Korber, B. Foley, B. Jeang, K.-T. Mellors, J. W. Wain-Hobson, S. 1996, Human retroviruses and AIDS 1996: A compilation and analysis of nucleic acid and amino acid sequences, Theoretical Biology and Biophysics, Group T-10, Mail Stop K710, Los Alamos National Laboratory, Los Alamos, New Mexico.
38. Nerurkar V. R., Nguyen H. T., Dashwood W. M., Hoffmann P. R., Yin C., Morens D. M., Kaplan A. H., Detels R., Yanagihara R. HIV type 1 subtype E in commercial sex workers and injection drug users in southern Vietnam. AIDS Res. Hum. Retroviruses. 12:1996;841-843.
39. Ou C.-Y., Takebe Y., Weniger B. G., Luo C.-C., Kalish M. L., Auwanit W., Yamazaki S., Gayle H. D., Young N. L., Schochetman G. Independent introduction of two major HIV-1 genotypes into distinct high-risk populations in Thailand. Lancet. 341:1993;1171-1174.
40. Peden K., Emerman M., Montagnier L. Changes in growth properties on passage in tissue culture of viruses derived from infectious molecular clones of HIV-1LAI, HIV-1MAL, and HIV-1ELI. Virology. 185:1991;661-672.
41. Pollard S., Rosa M., Rosa J., Wiley D. Truncated variants of gp120 bind CD4 with high affinity and suggest a minimum CD4 binding region. EMBO J. 11:1992;585-591.
42. Pope M., Frankel S. S., Mascola J. R., Trkola A., Isdell F., Birx D. L., Burke D. S., Ho D. D., Moore J. P. Human immunodeficiency virus type 1 strains of subtypes B and E replicate in cutaneous dendritic cell-T-cell mixtures without displaying subtype-specific tropism. J. Virol. 71:1997;8001-8007.
43. Sato H., Shiino T., Kodaka N., Taniguchi K., Tomita Y., Kato K., Miyakuni T., Takebe Y. Evolution and biological characterization of human immunodeficiency virus type 1 subtype E gp120 V3 sequences following horizontal and vertical virus transmission in a single family. J. Virol. 73:1999;3551-3559.
44. Scarlatti G., Tresoldi E., Bjorndal A., Fredriksson R., Colognesi C., Deng H. K., Malnati M. S., Plebani A., Siccardi A. G., Littman D. R., Fenyo E. M., Lusso P. In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression. Nat. Med. 3:1997;1259-1265.
45. Schuitemaker H., Koot M., Kootsra N. A., Wouter-Dercksen M., Goede R. E. Y. d., Steenwijk R. P. v., Lange J. M. A., Eftink-Schattenkerk J. K. M., Miedema F., Tersmette M. Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: Progression of disease is associated with a shift from monocytotropic to T-cell tropic virus populations. J. Virol. 66:1992;1354-1360.
46. Seibert S., Howell C., Hughes M., Hughes A. Natural selection on the gag, pol, and env genes of human immunodeficiency virus 1 (HIV-1). Mol. Biol. Evol. 12:1995;803-813.
47. Sharpless N. E., O'Brien W. A., Verdin E., Kufta C. V., Chen I. S., Dubois-Dalcq M. Human immunodeficiency virus type 1 tropism for brain microglial cells is determined by a region of the env glycoprotein that also controls macrophage tropism. J. Virol. 66:1992;2588-2593.
48. Shioda T., Levy J. A. Small amino acid changes in the V3 hypervariable region of gp120 can affect the T-cell-line and macrophage tropism of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA. 89:1992;9434-9438.
49. Simmonds P., Balfe P., Ludlam C., Bishop J., Brown A. Analysis of sequence diversity in hypervariable regions of the external glycoprotein of human immunodeficiency virus type 1. J. Virol. 64:1990;5840-5850.
50. Simmons G., Wilkinson D., Reeves J., Dittmar M., Beddows S., Weber J., Carnegie G., Desselberger U., Gray P., Weiss R., Clapham P. Primary, syncytium-inducing human immunodeficiency virus type 1 isolates are dual-tropic and most can use either Lestr or CCR5 as coreceptors for virus entry. J. Virol. 70:1996;8355-8360.
51. Soto-Ramirez L. E., Renjifo B., McLane M. F., Marlink R., O'Hara C., Sutthent R., Wasi C., Vithayasai P., Vithayasai V., Apichartpiyakul C., Auewarakul P., Pena Cruz V., Chui D. S., Osathanondh R., Mayer K., Lee T. H., Essex M. HIV-1 Langerhans' cell tropism associated with heterosexual transmission of HIV. Science. 271:1996;1291-1293.
52. Speck R., Wehrly K., Platt E., Atchison R., Charo I., Kabat D., Chesebro B., Goldsmith M. Selective employment of chemokine receptors as human immunodeficiency virus type 1 coreceptors determined by individual amino acids within the envelope V3 loop. J. Virol. 71:1997;7136-7139.
53. Tersmette M., de Goede R. E. Y., Al B. J. M., Winkel I. N., Gruters R. A., Cuypers H. T., Huisman H. G., Miedema F. Differential syncytium-inducing capacity of human immunodeficiency virus isolates: Frequent detection of syncytium-inducing isolates in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. J. Virol. 62:1988;2026-2032.
54. Tersmette M., Gruters R. A., de Wolf F., de Goede R. E., Lange J. M., Schellekens P. T., Goudsmit J., Huisman H. G., Miedema F. Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndrome: Studies on sequential HIV isolates. J. Virol. 63:1989;2118-2125.
55. Theodore T., Englund G., Buckler-White A., Buckler C., Martin M., Peden K. Construction and characterization of a stable full-length macrophage-tropic HIV type 1 molecular clone that directs the production of high titers of progeny virions. AIDS Res. Hum. Retroviruses. 12:1996;191-194.
56. Tscherning C., Alaeus A., Fredriksson R., Bjorndal A., Deng H., Littman D., Fenyo E., Albert J. Differences in chemokine coreceptor usage between genetic subtypes of HIV-1. Virology. 241:1998;181-188.
57. Weniger B. G., Takebe Y., Ou C.-Y., Yamazaki S. The molecular epidemiology of HIV in Asia. AIDS. 8:1994;S13-S28.
58. Westervelt P., Trowbridge D. B., Epstein L. G., Blumberg B. M., Li Y., Hahn B. H., Shaw G. M., Price R. W., Ratner L. Macrophage tropism determinants of human immunodeficiency virus type 1 in vivo. J. Virol. 66:1992;2577-2582.
59. Willey R. L., Smith D. H., Lasky L. A., Theodore T. S., Earl P. L., Moss B., Capon D. J., Martin M. A. In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity. J. Virol. 62:1988;139-147.
60. Wyatt R., Sullivan N., Thali M., Repke H., Ho D., Robinson J., Posner M., Sodroski J. Functional and immunologic characterization of human immunodeficiency virus type 1 envelope glycoproteins containing deletions of the major variable regions. J. Virol. 67:1993;4557-4565.
61. Xiao L., Owen S., Goldman I., Lal A., deJong J., Goudsmit J., Lal R. CCR5 coreceptor usage of non-syncytium-inducing primary HIV-1 is independent of phylogenetically distinct global HIV-1 isolates: Delineation of consensus motif in the V3 domain that predicts CCR-5 usage. Virology. 240:1998;83-92.
62. Yu X.-F., Wang Z., Beyrer C., Celentano D. D., Khamboonruang C., Allen E., Nelson K. Phenotypic and genotypic characteristics of human immunodeficiency virus type 1 from patients with AIDS in northern Thailand. J. Virol. 69:1995;4649-4655.
63. Zhang L., Carruthers C., He T., Huang Y., Cao Y., Wang G., Hahn B., Ho D. HIV type 1 subtypes, coreceptor usage, and CCR5 polymorphism. AIDS Res. Hum. Retroviruses. 13:1997;1357-1366.
64. Zhang L., Huang Y., He T., Cao Y., Ho D. HIV-1 subtype and second-receptor use. Nature. 383:1996;768.